JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hatfield, M.
Right arrow Articles by Churchill, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hatfield, M.
Right arrow Articles by Churchill, P.

Renal vascular and tubular effects of vanadate in the anesthetized rat

M Hatfield and P Churchill

The purpose of these experiments was to establish the renal vascular and tubular effects of vanadate. Three groups of adult rats were anesthetized with Na pentobarbital and given an i.v. infusion of a physiological saline solution at 0.055 ml/min. After a 60-min equilibration period, mean arterial blood pressure was measured, as were clearances of para-amino-hippuric acid (CPAH) and inulin (Cin), urine flow (V) and osmolality (Uosm) and the excretion rates of Na (UNaV), of K (UKV) and of Ca (UCaV). After the initial measurements, the i.v. infusion of physiological saline was continued in group 1 (controls), while vanadate was added to the saline and infused at 0.07 and 0.14 microM/min in groups 2 and 3. Then, all measurements were repeated. Compared with the control group, the following dose-dependent changes were observed in the vanadate-infused rats: increased mean arterial blood pressure, decreased CPAH (effective renal plasma flow), decreased Cin (glomerular filtration rate), increased V, UNaV and UCaV and decreased Uosm and UKV. Both the renal vascular and renal tubular effects of vanadate are similar to the renal effects of ouabain, previously reported by others. These effects can be explained by inhibitory effects of vanadate on Na,K-adenosine triphosphatase (ATPase) and/or Ca/ATPase activities of renal vascular and tubular cells.

Volume 217, Issue 2, pp. 406-410, 05/01/1981
Copyright © 1981 by American Society for Pharmacology and Experimental Therapeutics







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1981 by the American Society for Pharmacology and Experimental Therapeutics.